ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 64. Num. 12.
Pages 1220-1222 (December 2011)

Sandwich Stenting to Treat an Ostial Left Main Narrowing Following Transcatheter Aortic Valve Implantation

Implantación de stent «en sandwich» para tratar una estenosis del ostium de la principal izquierda tras implantación de válvula aórtica percutánea

Alfonso IelasiaAzeem LatibabMatteo MontorfanoaAntonio Colomboab

Options

To the Editor,

Transcatheter aortic valve implantation (TAVI) is becoming a feasible and effective therapeutic option in patients with severe symptomatic aortic stenosis at high risk for surgical aortic valve replacement (AVR). Despite being less invasive than conventional surgical AVR, TAVI is still associated with periprocedural complications including acute coronary obstruction.1

An 86-year-old woman with severe symptomatic aortic stenosis (peak gradient 100mmHg, mean gradient 68mmHg) presented to our institution with dyspnea (NYHA III) and rest angina (CCS 4) despite medical treatment. The patient was deemed to have a high surgical risk for AVR on the basis of age, general frailty, and the presence of a porcelain aorta, and was referred for transfemoral TAVI.

The procedure was performed as previously described.2 Following implantation of a 23-mm Sapien XT (Edwards Lifesciences, Irvine, California) aortic bioprosthesis (Figure 1A, video), the patient experienced acute hypotension with a blood pressure of 85/60mmHg (Figure 1B). Echocardiography showed severe left ventricular dysfunction without cardiac tamponade. Aortography excluded severe aortic regurgitation, aortic dissection, and aortic root rupture but left main coronary artery (LMCA) ostial obstruction was suspected (Figure 1C), especially as the patient developed ST-segment depression in the precordial leads (Figure 1D). The LMCA was engaged with a guiding catheter and angiography confirmed severe ostial narrowing, most probably due to displacement and obstruction by the calcific native valve leaflets. A coronary wire was advanced through the lesion (Figure 2A) and a 3.5×12mm Promus Element stent (Boston Scientific, Natick, Massachusetts) was implanted at the LMCA ostium. Subsequent coronary angiography revealed incomplete stent expansion, most likely due to acute stent recoil (Figure 2B). Postdilatation with a 3.5×12mm noncompliant balloon showed good expansion of the balloon (Figure 2C) but fluoroscopy again demonstrated dynamic recoil of the ostial part of the stent (Figure 2D). We concluded that the stent did not have sufficient radial strength to push the bulky leaflet away from the ostium. Thus we decided to implant a 3.5×9mm cobalt-chromium bare-metal stent within the first stent (“sandwich stenting”) to increase the radial strength of the scaffold without doubling the drug dose (Figure 2E). Following stent-in-stent implantation and postdilation with a 4.0×8mm noncompliant balloon inflated at 26 atm, acceptable stent expansion was obtained (Figure 2F) with hemodynamic and electrocardiographic normalization (Figure 2G and 2H).

Figure 1. A: Aortic valve implantation; B: Evidence of severe hypotension; C: Aortogram excluding aortic regurgitation, dissection or rupture; D: Diffuse ST segment depression.

Figure 2. A: Guidewire crossed distally to the narrowing; B: Angiographic view of acute stent recoil; C: Postdilatation showing optimal balloon expansion; D: Fluoroscopic evidence of stent recoil after postdilatation; E: Stent-in-stent positioning; F: Final result; G: Hemodynamic normalization; H: Electrocardiographic normalization.

Coronary artery ostial obstruction is an uncommon but severe complication following TAVI.1 Although rare, this event is potentially fatal as it can result in extensive myocardial ischemia. This was the first report of LMCA ostial obstruction from over 260 patients undergoing TAVI at our institution (0.4%). This complication can be related to procedural factors (inappropriately high positioning of the sealing cuff of an implanted valve or embolization of atheroma, calcium, thrombus or air) or anatomic features (narrow sinus of Valsalva, bulky leaflet calcifications, low-lying coronary ostia). These factors should be assessed preoperatively using multimodality imaging (echocardiography, aortography, and computed tomography) to allow appropriate procedural planning. Additionally, aortic root injection during the procedure (especially during balloon valvuloplasty) can help to further diagnose possible predisposing factors. Although hypotension and electrocardiographic modification following TAVI are often associated with acute coronary ostial obstruction, other procedural stressors may lead to a similar presentation, such as tamponade due to pacemaker, wire, or catheter perforation; hypovolemia due to access site related bleeding; ventricular-aortic junction rupture; aortic dissection; and acute severe mitral or aortic regurgitation.1 In this case, echocardiography demonstrating evidence of a well filled, globally hypokinetic left ventricle with no signs of pericardial effusion and immediate aortography to exclude an aortic complication was helpful in excluding other diagnoses. Prompt coronary angiography allowing visualization of acute ostial LMCA obstruction was diagnostic. Although surgical rescue can be performed, it is not the optimal solution in these high risk patients. Appropriate skills in interventional cardiology are fundamental to the successful management of this critical situation and to obtaining an immediate favorable outcome.

Appendix A. Supplementary material

Supplementary material associated with this section can be found in the online version available at doi:10.1016/j.rec.2011.02.003.

Appendix A. Supplementary material

Corresponding author: info@emocolumbus.it

Bibliography
[1]
Masson JB, Kovac J, Schuler G, Ye J, Cheung A, Kapadia S, et al..
Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications..
JACC Cardiovasc Interv. , (2009), 2 pp. 811-820
[2]
Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et al..
Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis..
Circulation. , (2007), 116 pp. 755-763
Are you a healthcare professional authorized to prescribe or dispense medications?